$0.41
-0.01 (-2.80%)
Performance
1D
+3.07%
1W
-41.58%
1M
-49.25%
3M
-51.00%
6M
-64.03%
1Y
-79.73%
YTD
-73.32%
Open$0.43
Previous Close$0.43
Day High$0.44
Day Low$0.41
52W High$2.13
52W Low$0.45
Volume—
Avg Volume7.63M
Market Cap117.91M
P/E Ratio—
EPS$-0.11
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$0.81
Below
SMA 200
$1.13
Below
RSI (14)
30.7
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+8,954.6% upside
Current
$0.41
$0.41
Target
$37.45
$37.45
$22.27
$37.45 avg
$46.32
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 261.85M | 281.19M | 65.59M |
| Net Income | -5,929,645 | -5,730,971 | -3,878,355 |
| Profit Margin | -2.3% | -2.2% | -5.9% |
| EBITDA | 26.06M | 26.58M | -4,128,349 |
| Free Cash Flow | — | — | -1,979,346 |
| Rev Growth | -6.9% | -6.9% | +11.6% |
| Debt/Equity | 5.94 | 5.94 | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |